Cardiogenic Shock
What is cardiogenic shock?
Shock is a condition in which the blood pressure is very low and the body does not get all the blood it needs. Shock can happen when you suddenly lose a lot of blood, you have a severe allergic reaction, or your heart is not pumping well. When low blood pressure happens because the heart is not pumping well, the problem is called cardiogenic shock.
Shock is an emergency and requires medical care right away. Untreated shock usually causes death.
What is the cause?
The main cause of cardiogenic shock is a heart attack. A heart attack happens when the heart muscle does not get enough blood and oxygen. The lack of blood makes the heart muscle weak. Sometimes part of the muscle dies. If the muscle is hurt, the heart cannot pump blood very well.
What are the symptoms?
When you are in shock and your blood pressure is very low, symptoms may include:
- Extreme weakness
- Sweating
- Pale skin color
- Cold hands and feet
- Less urine
- Nausea
- Fast, shallow breathing
- Fainting (loss of consciousness)
If the damage caused by a heart attack is bad, the signs and symptoms of cardiogenic shock may show up right away. If the heart attack is less severe, shock may not happen for several hours.
How is it diagnosed?
Your healthcare provider will review your medical history, examine you, and measure your blood pressure. You may have the following tests:
- A heart monitor can show abnormal heart rates or rhythms.
- An ECG (electrocardiogram) measures and records the electrical activity of your heart. It gives early information about areas of heart muscle that are damaged.
- Your blood oxygen level can be monitored by a sensor attached to your finger or ear.
- Blood tests may be done to check for damage to the heart, kidneys, or liver and other problems.
- A chest X-ray can show abnormal heart size and signs of heart failure (poor pumping by the heart).
- An ultrasound scan called an echocardiogram uses sound waves and their echoes passed through your body from a small device held against your skin. The sound waves make pictures of the inside of the heart to look at the heart valves, blood flow, and how well the heart muscle is pumping.
- A coronary angiogram (heart catheterization) uses X-rays, dye injected into a vein, and a small tube called a catheter inserted into a blood vessel to look at your blood vessels and heart.
How is it treated?
Cardiogenic shock is treated by medical staff in an emergency room or in the hospital’s intensive care unit.
When a heart attack causes shock, treatment includes medicines to:
- Restore blood flow to the damaged part of the heart muscle.
- Raise blood pressure.
Medicine may not be enough to treat the shock. The heart muscle may need help pumping. Mechanical devices such as an intra-aortic balloon pump (IABP) may be used for a short time. IABP helps the heart so it doesn’t have to work as hard and increases blood flow to the heart and the rest of the body.
How can I prevent cardiogenic shock?
Call 911 for emergency help right away if you have the following symptoms of a possible heart attack:
- You have chest discomfort that lasts for more than 5 minutes, or that goes away and comes back. It can feel like uncomfortable pressure, squeezing, fullness, or burning.
- You have chest discomfort with lightheadedness.
- You have chest pain that goes beyond your chest to one or both arms, neck, jaw, shoulder, back, or stomach.
- You have trouble breathing, with or without chest pain.
- You have chest discomfort along with sweating, indigestion, vomiting, or feeling sick to your stomach.
Cardiogenic Shock: References
Berger, PB, Tuttle, RH, Holmes, DR, et al, for the GUSTO-I Investigators. One-year survival among patients with acute myocardial infarction complicated by cardiogenic shock, and its relation to early revascularization: Results from the GUSTO-I trial. Circulation 1999; 99:873.
Dzavik, V, Sleeper, LA, Cocke, TP. Early revascularization is associated with improved survival in elderly patients with acute myocardial infarction complicated by cardiogenic shock: a report from the SHOCK Trial Registry. Eur Heart J 2003; 24:828.
Goldberg, RJ, Spencer, FA, Gore, JM, et al. Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective. Circulation 2009; 119:1211.
Hochman, JS, Buller, CE, Sleeper, LA, et al. Cardiogenic shock complicating acute myocardial infarction–etiologies, management and outcome: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol 2000; 36:1063.
Hochman, JS, Sleeper, LA, Webb, JG, et al. Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. JAMA 2006; 295:2511.
Hochman, JS. Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. Circulation 2003; 107:2998.
King, SB, 3rd, Smith, SC Jr, Hirshfeld, JW Jr, et al. 2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association task force on practice guidelines: 2007 writing group to review new evidence and update the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention, writing on behalf of the 2005 writing committee. Circulation 2008; 117:261. Available at: http://www.circ.ahajournals.org (accessed January 29, 2008).
Reynolds HR, Hochman JS. Cardiogenic shock: current concepts and improving outcomes. Circulation 2008; 117:686.
Sleeper, LA, Ramanathan, K, Picard, MH, et al. Functional status and quality of life after emergency revascularization for cardiogenic shock complicating acute myocardial infarction. J Am Coll Cardiol 2005; 46:266.
Smith, SC Jr, Feldman, TE, Hirshfeld, JW Jr, et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention).J Am Coll Cardiol 2006; 47:e1. Available at: http://www.acc.org/qualityandscience/clinical/statements.htm (accessed September 18, 2007).
Webb, JG, Sleeper, LA, Buller, CE, et al. Implications of the timing of onset of cardiogenic shock after acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shock? J Am Coll Cardiol 2000; 36:1084.
Wong, SC, Sleeper, LA, Monrad, ES, et al. Absence of gender differences in clinical outcomes in patients with cardiogenic shock complicating acute myocardial infarction. A report from the SHOCK Trial Registry. J Am Coll Cardiol 2001; 38:1395.